NO CASES OF ENDOPHTHALMITIS AFTER 20,293 INTRAVITREAL INJECTIONS IN AN OPERATING ROOM SETTING
出版年份 2013 全文链接
标题
NO CASES OF ENDOPHTHALMITIS AFTER 20,293 INTRAVITREAL INJECTIONS IN AN OPERATING ROOM SETTING
作者
关键词
-
出版物
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
Volume 34, Issue 5, Pages 951-957
出版商
Ovid Technologies (Wolters Kluwer Health)
发表日期
2013-12-06
DOI
10.1097/iae.0000000000000071
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Endophthalmitis following intravitreal anti-VEGF injections in ambulatory surgical centre facility: incidence, management and outcome
- (2013) Kopal Mithal et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Safety of ranibizumab in routine clinical practice: 1-year retrospective pooled analysis of four European neovascular AMD registries within the LUMINOUS programme
- (2013) Frank G Holz et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Minimizing the endophthalmitis rate following intravitreal injections using 0.25 % povidone–iodine irrigation and surgical mask
- (2013) Hiroyuki Shimada et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial
- (2013) Usha Chakravarthy et al. LANCET
- Long-term Outcomes of Ranibizumab Therapy for Diabetic Macular Edema: The 36-Month Results from Two Phase III Trials
- (2013) David M. Brown et al. OPHTHALMOLOGY
- A 4-Year Longitudinal Study of 555 Patients Treated with Ranibizumab for Neovascular Age-related Macular Degeneration
- (2013) Annette Rasmussen et al. OPHTHALMOLOGY
- Twelve-Month Efficacy and Safety of 0.5 mg or 2.0 mg Ranibizumab in Patients with Subfoveal Neovascular Age-related Macular Degeneration
- (2013) Brandon G. Busbee et al. OPHTHALMOLOGY
- Ranibizumab versus Bevacizumab for Neovascular Age-related Macular Degeneration: Results from the GEFAL Noninferiority Randomized Trial
- (2013) Laurent Kodjikian et al. OPHTHALMOLOGY
- Antibiotic Resistance of Ocular Surface Flora With Repeated Use of a Topical Antibiotic After Intravitreal Injection
- (2013) Vivian T. Yin et al. JAMA Ophthalmology
- Four-Year Treatment Results of Neovascular Age-Related Macular Degeneration With Ranibizumab and Causes for Discontinuation of Treatment
- (2012) Mads Krüger Falk et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Post-intravitreal anti-VEGF endophthalmitis in the United Kingdom: incidence, features, risk factors and outcomes
- (2012) D A M Lyall et al. EYE
- Effect of Lidocaine Gel Anesthesia on Endophthalmitis Rates Following Intravitreal Injection
- (2012) Eleonora M. Lad et al. OPHTHALMIC SURGERY LASERS & IMAGING
- Ranibizumab for Macular Edema Due to Retinal Vein Occlusions
- (2012) Jeffrey S. Heier et al. OPHTHALMOLOGY
- HORIZON: An Open-Label Extension Trial of Ranibizumab for Choroidal Neovascularization Secondary to Age-Related Macular Degeneration
- (2012) Michael A. Singer et al. OPHTHALMOLOGY
- Changes in Antibiotic Resistance Patterns of Conjunctival Flora Due to Repeated Use of Topical Antibiotics after Intravitreal Injection
- (2012) Eugene Milder et al. OPHTHALMOLOGY
- Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration
- (2012) Daniel F. Martin et al. OPHTHALMOLOGY
- Incidence of Endophthalmitis and Use of Antibiotic Prophylaxis after Intravitreal Injections
- (2012) Crystal S.Y. Cheung et al. OPHTHALMOLOGY
- Prophylaxis for Endophthalmitis Following Intravitreal Injection: Antisepsis and Antibiotics
- (2011) Charles C. Wykoff et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Bacterial Dispersal Associated With Speech in the Setting of Intravitreous Injections
- (2011) Joanne C. Wen ARCHIVES OF OPHTHALMOLOGY
- Evaluation of the Incidence of Endophthalmitis after Intravitreal Injection of Anti-Vascular Endothelial Growth Factor
- (2011) Maiko Inoue et al. OPHTHALMOLOGICA
- Sustained Benefits from Ranibizumab for Macular Edema Following Branch Retinal Vein Occlusion: 12-Month Outcomes of a Phase III Study
- (2011) David M. Brown et al. OPHTHALMOLOGY
- Outcomes and Risk Factors Associated with Endophthalmitis after Intravitreal Injection of Anti-Vascular Endothelial Growth Factor Agents
- (2011) Chirag P. Shah et al. OPHTHALMOLOGY
- Sustained Benefits from Ranibizumab for Macular Edema following Central Retinal Vein Occlusion: Twelve-Month Outcomes of a Phase III Study
- (2011) Peter A. Campochiaro et al. OPHTHALMOLOGY
- A SYSTEMATIC REVIEW OF THE ADVERSE EVENTS OF INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTIONS
- (2011) Margriet I Van der Reis et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- PROPHYLACTIC ANTIBIOTIC USE AFTER INTRAVITREAL INJECTION
- (2011) Shabari S Bhatt et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION
- (2011) Eric Chen et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- ENDOPHTHALMITIS AFTER INTRAVITREAL ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR ANTAGONISTS
- (2011) Andrew A Moshfeghi et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Survey of Intravitreal Injection Techniques Among Retinal Specialists in the United States
- (2010) Amy E. Green-Simms et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Antibiotic Susceptibility Patterns of Ocular Bacterial Flora in Patients Undergoing Intravitreal Injections
- (2010) Jason M. Moss et al. OPHTHALMOLOGY
- Risk of Endophthalmitis After Intravitreal Drug Injection When Topical Antibiotics Are Not Required
- (2009) Abdhish R. Bhavsar ARCHIVES OF OPHTHALMOLOGY
- Incidence and management of acute endophthalmitis after intravitreal bevacizumab (Avastin) injection
- (2009) O Artunay et al. EYE
- Preoperative topical moxifloxacin 0.5% and povidone–iodine 5.0% versus povidone–iodine 5.0% alone to reduce bacterial colonization in the conjunctival sac
- (2009) Orly Halachimi-Eyal et al. JOURNAL OF CATARACT AND REFRACTIVE SURGERY
- A Phase IIIb Study to Evaluate the Safety of Ranibizumab in Subjects with Neovascular Age-related Macular Degeneration
- (2009) David S. Boyer et al. OPHTHALMOLOGY
- A Prospective Randomized Evaluation of Topical Gatifloxacin on Conjunctival Flora in Patients Undergoing Intravitreal Injections
- (2009) Jason M. Moss et al. OPHTHALMOLOGY
- INFECTIOUS ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION OF ANTIANGIOGENIC AGENTS
- (2009) TERESA DIAGO et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- EVALUATION OF SAFETY FOR BILATERAL SAME-DAY INTRAVITREAL INJECTIONS OF ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY
- (2009) LUIZ H. LIMA et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Endophthalmitis Associated with Intravitreal Anti-Vascular Endothelial Growth Factor Therapy Injections in An Office Setting
- (2008) Suman Pilli et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Pegaptanib sodium for neovascular age-related macular degeneration: third-year safety results of the VEGF Inhibition Study in Ocular Neovascularisation (VISION) trial
- (2008) L J Singerman et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- INCIDENCE OF ACUTE ONSET ENDOPHTHALMITIS FOLLOWING INTRAVITREAL BEVACIZUMAB (AVASTIN) INJECTION
- (2008) JOHN O. MASON et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- INCIDENCE OF ENDOPHTHALMITIS RELATED TO INTRAVITREAL INJECTION OF BEVACIZUMAB AND RANIBIZUMAB
- (2008) DAVID R. FINTAK et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search